EE474 Cost-Effectiveness Model for a Novel Functional ASSAY Versus Provider Selection of Third-Line Treatment of Patients with Refractory Metastatic Colorectal Cancer
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.722
https://www.valueinhealthjournal.com/article/S1098-3015(22)00923-8/fulltext
Title :
EE474 Cost-Effectiveness Model for a Novel Functional ASSAY Versus Provider Selection of Third-Line Treatment of Patients with Refractory Metastatic Colorectal Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00923-8&doi=10.1016/j.jval.2022.04.722
First page :
Section Title :
Open access? :
No
Section Order :
10653